title: New strategies and patent therapeutics in EBV-associated diseases.
authors.affiliation: Department of Microbiology, School of Medicine, University of Granada, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Villegas
authors.forename: O
authors.initials: O
authors.lastname: Santiago
authors.forename: A
authors.initials: A
authors.lastname: Sorlózano
authors.forename: J
authors.initials: J
authors.lastname: Gutierrez
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000821:virology; D018984:Epitopes, T-Lymphocyte / Q000276:immunology; D020031:Epstein-Barr Virus Infections / Q000517:prevention & control / Q000628:therapy* / Q000821:virology; D015316:Genetic Therapy; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000254:growth & development / Q000472:pathogenicity*; D006801:Humans; D009369:Neoplasms / Q000821:virology; D010330:Patents as Topic; D022223:Vaccines, Subunit / Q000276:immunology
chemical_list: D000998:Antiviral Agents; D018984:Epitopes, T-Lymphocyte; D022223:Vaccines, Subunit